Atmo Biosciences has developed the Atmo® Gas Capsule, an innovative ingestible device designed to measure gases produced in the gastrointestinal (GI) tract. This capsule provides real-time data on gut motility by assessing transit times across various regions of the GI tract, including the stomach, small bowel, and colon. The Atmo Gas Capsule System utilizes onboard sensors to monitor temperature, hydrogen, carbon dioxide, and oxygen levels, as well as capsule movement, to accurately determine its location and the transit time of food contents. This technology is particularly valuable for diagnosing motility disorders such as gastroparesis and slow transit constipation, which can significantly impact patients' quality of life.

Currently classified as an investigational device, the Atmo Gas Capsule is undergoing clinical investigations and is pending FDA 510(k) clearance for commercial use. The device's ability to wirelessly transmit data allows for aggregation and analysis in the cloud, facilitating better patient reporting and management of GI disorders. Atmo Biosciences is actively engaged in clinical studies to validate the efficacy of the capsule, aiming to provide healthcare professionals with a comprehensive tool for diagnosing and treating functional gut disorders, which affect a substantial portion of the global population.

Australia

The Atmo Gas Capsule is a world first patented solution to accurately profile the gases within the gut, leading to better diagnosis and treatment of gastrointestinal disorders.

Atmo Biosciences

Company Details